Stock Events

Stock Events

Oncolys BioPharma (4588.TSE) Q1 2025 Earnings

7FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-24

-22

-19

-17

Details

Expected EPS

N/A

Actual EPS

-17

Surprise EPS

-17

Surprise Percent

+∞%

Description

Oncolys BioPharma (4588.TSE) has reported earnings of -17 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.